Henrik Watz Featured in Free Educational Presentation Available for HCPs on COPD with Type 2 Inflammation

Congratulations to Henrik Watz, MD, on his exceptional presentation at the 2024 European Respiratory Society (ERS) ADVENT COPD Symposia!

Dr. Watz, Medical Director and Principal Investigator at Velocity Clinical Research in Ahrensburg, Germany, joined Drs. Mona Bafadhel and Alberto Papi for a dynamic discussion, A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation.

Their presentation explored:
– The pathophysiology of COPD with type 2 inflammation.
– The role of type 2 cytokines and mediators as markers or drivers of disease.
– Current and emerging biologic therapies to address the cumulative burden of COPD.

Thanks to Sanofi and Regeneron Pharmaceuticals, health care professionals can now watch this insightful presentation for free to gain a deeper understanding of COPD with type 2 inflammation and its innovative therapeutic options.

Don’t miss the opportunity to learn from leading experts in respiratory health: https://www.emjreviews.com/respiratory/video/2024-european-respiratory-society-ers-advent-copd-symposia/

Posted in , , ,

Quality. Continuity. Velocity.